On Tuesday, Nov. 5, as part of the Johns Hopkins Medicine’s Department of Neurology and Neurosurgery Neuroimmunology Seminar Series, Dr. Amber Salter delivered an overview of her ongoing work ...

Multiple sclerosis (MS) is a lifelong condition that impacts the brain ... that a common type of discomfort in MS is unusual ...

The researchers utilized a Fra-2 transgenic mouse model that encompasses many of the features of systemic sclerosis in humans, including spontaneous systemic inflammation and fibrosis in the lungs, ...

The results from a new study of the multi-kinase inhibitor fexagratinib in mouse models are raising hopes that the therapy ...

The California biotech has drawn partnerships with Eli Lilly and J&J on the promise of its approach to rebalancing the immune ...

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis ...

Three patients have undergone CAR T-cell therapy, which genetically alters their immune system to protect their organs ...

that surrounds neurons—such as multiple sclerosis. A study published in the Journal of Biological Chemistry found a plant-derived flavonoid—a type of chemical compound—called sulfuretin ...

The Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments, ...

Three patients in the UK have received a”groundbreaking” treatment for lupus on the NHS, which experts hope could eradicate the need for lifelong drugs. Until now, CAR T-cell therapy in the UK has ...

Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic ...

The therapy works by genetically modifying cells to enable the body’s own immune system to recognise and attack problem cells ...